Loading stock data…
$21.08-0.13 (-0.61%)
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.
Fresenius Medical Care AG in the Healthcare sector is trading at $21.08 with a market capitalization of $12.7B. Wall Street consensus targets $23.69 (7 analysts), implying a +12.4% move over the next 12 months. The stock is currently near its 52-week low of $20.02, remaining 6.3% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.86B↑ | $4.61B↓ | $5.07B↑ | $4.88B↑ | $4.79B |
| Gross Profit | $1.31B↑ | $1.18B↓ | $1.39B↑ | $1.24B↑ | $1.21B |
| Operating Income | $537.27M↑ | $375.56M↓ | $548.98M↑ | $501.72M↑ | $379.78M |
| Net Income | $218.38M↑ | $117.53M↓ | $327.08M↑ | $274.80M↑ | $225.27M |
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a ne...